Page last updated: 2024-12-06

palladium chloride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Palladium chloride, also known as palladium(II) chloride, is a red-brown, crystalline solid with the formula PdCl2. It is a common starting material for the synthesis of other palladium compounds and catalysts. It is synthesized by the reaction of palladium metal with chlorine gas or by dissolving palladium metal in aqua regia. Palladium chloride is used as a catalyst in organic reactions, such as the Suzuki coupling reaction. It is also used in the production of electronic devices and in the plating of metal surfaces. The compound is studied for its use in various chemical processes due to its catalytic activity. It is also of interest for its potential applications in medicine and in the development of new materials.'

palladium chloride: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

palladium(II) chloride : A palladium coordination entity consisting of palladium(II) bound to two chlorine atoms. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID24290
CHEBI ID53434
MeSH IDM0052884

Synonyms (65)

Synonym
AC-18128
AKOS015833820
palladium (ii) chloride
pd(ii) chloride
nsc 146183
ccris 6263
hsdb 4362
nci-c60184
einecs 231-596-2
enplate activator 440
7647-10-1
wln: pd g2
palladium chloride (pdcl2)
dichloropalladium
palladium dichloride
palladium(ii) chloride
nsc146183
palladous chloride
palladium(2+) chloride
palladium(ii) chloride, >=99.9%
palladium(ii) chloride, reagentplus(r), 99%
palladium(ii) chloride, 99.999%
palladium chloride (2+)
palladium chloride
palladium(ii) chloride, anhydrous, 60% pd basis
palladium(ii) chloride, anhydrous, 59-60% palladium (pd) basis
palladium ii chloride
FT-0656183
CHEBI:53434 ,
pdcl2
palladium dichloride
unii-n9214ir8n7
BP-12254
JC10152
palladium(ii)chloride
cl2pd
palladium-ii-chloride
dichloropalladium(ii)
palladium chloride (ii)
palladium-dichloride
palladium (ii) dichloride
dichloro-palladium (ii)
palladium-(ii)dichloride
palladium(ii)-chloride
dichloropalladium (11)
dichloro palladium
palladium chloride(ii)
dichloro palladium (ii)
dichloro-palladium-(ii)
dichloro-palladium(ii)
palladium(ii) dichloride
dichloropalladium(11)
dichloropalladium (ii)
PIBWKRNGBLPSSY-UHFFFAOYSA-L
dichloro palladium(ii)
palladium(ii)dichloride
palladium(ii) chloride, premion?
palladium(ii) chloride, jis special grade, >=99.0%
palladium(ii) chloride, puriss., 60.0%
palladium(ii) chloride, vetec(tm) reagent grade, 98%
palladium (ii) chloride, trace metals grade 99.9%
Q419904
CS-W020882
palladium( cento) chloride
palladium(ii) chloride, 59% pd

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" In contrast, the palladium complex was found to be more toxic for the LY-R cells than for the LY-S cells."( Differential toxic effect of cis-platinum(II) and palladium(II) chlorides complexed with methyl 3,4-diamine-2,3,4,6-tetradeoxy-alpha-L-lyxo-hexopyranoside in mouse lymphoma cell lines differing in DSB and NER repair ability.
Bouzyk, E; Fokt, I; Fuks, L; Kruszewski, M; Lewandowski, W; Oldak, T; Priebe, W; Samochocka, K, 2003
)
0.32

Dosage Studied

ExcerptRelevanceReference
" The proposed method was successfully applied for the determination of these compounds in their dosage forms."( Spectrophotometric complexation of cephalosporins with palladium (II) chloride in aqueous and non-aqueous solvents.
Bagheri Gh, A; Rezvani, M; Roshanzamir, S; Yosefi rad, A, 2012
)
0.38
" For all metals, the dose-response curve followed a biphasic pattern that is typical of hormesis."( Thyroid Stem Cells But Not Differentiated Thyrocytes Are Sensitive to Slightly Increased Concentrations of Heavy Metals.
Franco, A; Gianì, F; Masto, R; Pandini, G; Trovato, MA; Vigneri, R, 2021
)
0.62
"The results demonstrated that once-daily dosing of Compound 1 significantly suppressed the PTX-induced behavioral pain responses dose-dependently."( Anti-neuropathic pain activity of a cationic palladium (II) dithiocarbamate by suppressing the inflammatory mediators in paclitaxel-induced neuropathic pain model.
Khan, A; Khan, AU; Khan, S; Khan, SZ; Naveed, M; Rehman, ZU; Shal, B; Ullah, R, 2021
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
catalystA substance that increases the rate of a reaction without modifying the overall standard Gibbs energy change in the reaction.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
palladium coordination entity
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (168)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (7.14)18.7374
1990's21 (12.50)18.2507
2000's52 (30.95)29.6817
2010's72 (42.86)24.3611
2020's11 (6.55)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 53.16

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index53.16 (24.57)
Research Supply Index5.21 (2.92)
Research Growth Index4.91 (4.65)
Search Engine Demand Index86.82 (26.88)
Search Engine Supply Index2.04 (0.95)

This Compound (53.16)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (1.10%)5.53%
Reviews2 (1.10%)6.00%
Case Studies5 (2.76%)4.05%
Observational1 (0.55%)0.25%
Other171 (94.48%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]